FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sudhakar Chintharlapalli

Research Profile

Anatomy

Physiology

Chemicals & Drugs

Living Beings

Procedures

Xenograft Model Antitumor Assays

Disorders

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
Damien Gerald; Sudhakar Chintharlapalli; Hellmut G Augustin; Laura E Benjamin
Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy.
Beverly L Falcon; Linda N Lee; Don McClure; Dyke P McEwen; Kuldeep Neote; Belinda O'Clair; Julie Stewart; Michelle L Swearingen; Mark T Uhlik; Kevin Allard; Yuefeng Chen; Glenn F Evans; Sudhakar Chintharlapalli
Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibition.
KYOUNGHYUN Kim; Ju Seog Lee; Yun-Yong Park; Satya S Pathi; Gayathri Chadalapaka; Sudhakar Chintharlapalli; Sung-Gook Cho; Un-Ho Jin; Stephen Safe
Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sudhakar Chintharlapalli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Damien Gerald; Sudhakar Chintharlapalli; Hellmut G Augustin; Laura E Benjamin
Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy.
Cancer research 2013;73(6):1649-57.
2013: Beverly L Falcon; Linda N Lee; Don McClure; Dyke P McEwen; Kuldeep Neote; Belinda O'Clair; Julie Stewart; Michelle L Swearingen; Mark T Uhlik; Kevin Allard; Yuefeng Chen; Glenn F Evans; Sudhakar Chintharlapalli
Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibition.
Journal of hematology & oncology 2013;6(1):31.
2012: KYOUNGHYUN Kim; Ju Seog Lee; Yun-Yong Park; Satya S Pathi; Gayathri Chadalapaka; Sudhakar Chintharlapalli; Sung-Gook Cho; Un-Ho Jin; Stephen Safe
Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters.
Molecular cancer therapeutics 2012;11(9):1852-62.
2011: Timothy Meier; Michele C Smith; Julie Stewart; Mark Uhlik; Robert Van Horn; Xiang Ye; Debra Young; Darryl Ballard; Wayne Blosser; Andrew Capen; Marcio Chedid; Sudhakar Chintharlapalli; James Cook; Kelly Credille; Michele S Dowless; Glenn Evans; Lysiane Huber; Robert Ilaria; Louis F Stancato
Tasisulam sodium, an antitumor agent that inhibits mitotic progression and induces vascular normalization.
Molecular cancer therapeutics 2011;10(11):2168-78.
2011: Sudhakar Chintharlapalli; Un-Ho Jin; Syng-Ook Lee; Ping Lei; Sabitha Papineni; Libero Santarpia; Steven I Sherman; Stephen Safe
Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteins.
Molecular carcinogenesis 2011;50(9):655-67.
2011: Sudhakar Chintharlapalli; Ping Lei; Sabitha Papineni; Satya Pathi; Stephen Safe
Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
BMC cancer 2011;11():371.
2010: Syng-Ook Lee; Maen Abdelrahim; Kyungsil Yoon; Sudhakar Chintharlapalli; Sabitha Papineni; KYOUNGHYUN Kim; Huamin Wang; Stephen Safe
Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.
Cancer research 2010;70(17):6824-36.
2010: Jun-Hee Kim; Ji-Youn Jung; Jung-Hyun Shim; Jin Kim; Kyeong-Hee Choi; Ji-Ae Shin; Eun-Sun Choi; Syng-Ook Lee; Sudhakar Chintharlapalli; Ki Han Kwon; Dae-Ho Leem; Nam-Pyo Cho; Sung-Dae Cho
Apoptotic Effect of Tolfenamic Acid in KB Human Oral Cancer Cells: Possible Involvement of the p38 MAPK Pathway.
Journal of clinical biochemistry and nutrition 2010;47(1):74-80.
2010: Jingjing Guo; Sudhakar Chintharlapalli; Syng-Ook Lee; Sung Dae Cho; Ping Lei; Sabitha Papineni; Stephen Safe
Peroxisome proliferator-activated receptor gamma-dependent activity of indole ring-substituted 1,1-bis(3'-indolyl)-1-(p-biphenyl)methanes in cancer cells.
Cancer chemotherapy and pharmacology 2010;66(1):141-50.
2010: Sung Dae Cho; Syng-Ook Lee; Sudhakar Chintharlapalli; Maen Abdelrahim; Shaheen Khan; Kyungsil Yoon; Ashish M Kamat; Stephen Safe
Activation of nerve growth factor-induced B alpha by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth.
Molecular pharmacology 2010;77(3):396-404.
2010: Kyeong-Hee Choi; Hyung-Kook Kim; Jun-Hee Kim; Eun-Sun Choi; Ji-Ae Shin; Syng-Ook Lee; Sudhakar Chintharlapalli; Stephen Safe; Maen Abdelrahim; Gu Kong; Hong Seok Choi; Ji-Youn Jung; Hyun-Tae Cho; Nam-Pyo Cho; Sung-Dae Cho
The p38 MAPK pathway is critical for 5,5'-dibromodiindolylmethane-induced apoptosis to prevent oral squamous carcinoma cells.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2010;19(2):153-9.
2009: Sudhakar Chintharlapalli; Sabitha Papineni; Maen Abdelrahim; Ala Abudayyeh; Indira Jutooru; Gayathri Chadalapaka; Fei Wu; Susanne U Mertens-Talcott; Kathy Vanderlaag; Sung-Dae Cho; Roger Smith; Stephen Safe
Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
International journal of cancer. Journal international du cancer 2009;125(8):1965-74.
2009: Indira Jutooru; Gayathri Chadalapaka; Sudhakar Chintharlapalli; Sabitha Papineni; Stephen Safe
Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative.
Molecular carcinogenesis 2009;48(8):692-702.
2009: Syng-Ook Lee; Sudhakar Chintharlapalli; Shengxi Liu; Sabitha Papineni; Sung-Dae Cho; Kyungsil Yoon; Stephen Safe
p21 expression is induced by activation of nuclear nerve growth factor-induced Balpha (Nur77) in pancreatic cancer cells.
Molecular cancer research : MCR 2009;7(7):1169-78.
2009: Sabitha Papineni; Sudhakar Chintharlapalli; Maen Abdelrahim; Syng-Ook Lee; Robert C. Burghardt; Ala Abudayyeh; Cheryl Baker; Luis Herrera; Stephen Safe
Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.
Carcinogenesis 2009;30(7):1193-201.
2008: Stephen Safe; Sabitha Papineni; Sudhakar Chintharlapalli
Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs.
Cancer letters 2008;269(2):326-38.
2008: Sung Dae Cho; Sudhakar Chintharlapalli; Maen Abdelrahim; Sabitha Papineni; Shengxi Liu; Jingjing Guo; Ping Lei; Ala Abudayyeh; Stephen Safe
5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells.
Molecular cancer therapeutics 2008;7(7):2109-20.
2008: Gayathri Chadalapaka; Indira Jutooru; Sudhakar Chintharlapalli; Sabitha Papineni; Roger Smith; Xiangrong Li; Stephen Safe
Curcumin decreases specificity protein expression in bladder cancer cells.
Cancer research 2008;68(13):5345-54.
2008: Jun Hong; Ismael Samudio; Sudhakar Chintharlapalli; Stephen Safe
1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methanes decrease mitochondrial membrane potential and induce apoptosis in endometrial and other cancer cell lines.
Molecular carcinogenesis 2008;47(7):492-507.
2008: Ping Lei; Maen Abdelrahim; Sung Dae Cho; Shengxi Liu; Sudhakar Chintharlapalli; Stephen Safe
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase.
Carcinogenesis 2008;29(6):1139-47.
2008: Sung Dae Cho; Ping Lei; Maen Abdelrahim; Kyungsil Yoon; Shengxi Liu; Jingjing Guo; Sabitha Papineni; Sudhakar Chintharlapalli; Stephen Safe
1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells.
Molecular carcinogenesis 2008;47(4):252-63.
2008: Sabitha Papineni; Sudhakar Chintharlapalli; Stephen Safe
Methyl 2-cyano-3,11-dioxo-18 beta-olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells.
Molecular pharmacology 2008;73(2):553-65.
2007: Susanne U Mertens-Talcott; Sudhakar Chintharlapalli; Xiangrong Li; Stephen Safe
The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
Cancer research 2007;67(22):11001-11.
2007: Melissa York; Maen Abdelrahim; Sudhakar Chintharlapalli; Salina D Lucero; Stephen Safe
1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(22 Pt 1):6743-52.
2007: Sudhakar Chintharlapalli; Sabitha Papineni; Shengxi Liu; Indira Jutooru; Gayathri Chadalapaka; Sung Dae Cho; Rajesh S Murthy; Youngjae You; Stephen Safe
2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells.
Carcinogenesis 2007;28(11):2337-46.
2007: Lavanya Reddivari; Jairam Vanamala; Sudhakar Chintharlapalli; Stephen H Safe; J Creighton Miller
Anthocyanin fraction from potato extracts is cytotoxic to prostate cancer cells through activation of caspase-dependent and caspase-independent pathways.
Carcinogenesis 2007;28(10):2227-35.
2007: Sudhakar Chintharlapalli; Sabitha Papineni; Indira Jutooru; Alan McAlees; Stephen Safe
Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.
Molecular cancer therapeutics 2007;6(5):1588-98.
2007: Sudhakar Chintharlapalli; Sabitha Papineni; Shashi K Ramaiah; Stephen Safe
Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.
Cancer research 2007;67(6):2816-23.
2007: Sudhakar Chintharlapalli; Sabitha Papineni; Stephen Safe
1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways.
Molecular pharmacology 2007;71(2):558-69.
2007: Sung Dae Cho; Kyungsil Yoon; Sudhakar Chintharlapalli; Maen Abdelrahim; Ping Lei; Stanley Hamilton; Shaheen Khan; Shashi K Ramaiah; Stephen Safe
Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways.
Cancer research 2007;67(2):674-83.
2006: Sudhakar Chintharlapalli; Sabitha Papineni; Stephen Safe
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARgamma-dependent and PPARgamma-independent pathways.
Molecular cancer therapeutics 2006;5(5):1362-70.
2006: Wassim Kassouf; Sudhakar Chintharlapalli; Maen Abdelrahim; Gina M Nelkin; Stephen Safe; Ashish M Kamat
Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.
Cancer research 2006;66(1):412-8.
2005: Sudhakar Chintharlapalli; Sabitha Papineni; Seung Joon Baek; Shengxi Liu; Stephen Safe
1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and nonsteroidal anti-inflammatory drug-activated gene-1.
Molecular pharmacology 2005;68(6):1782-92.
2005: Sudhakar Chintharlapalli; Robert C. Burghardt; Sabitha Papineni; Shashi K Ramaiah; Kyungsil Yoon; Stephen Safe
Activation of Nur77 by selected 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways.
The Journal of biological chemistry 2005;280(26):24903-14.
2005: Sudhakar Chintharlapalli; Sabitha Papineni; Marina Konopleva; Michael Andreef; Ismael Samudio; Stephen Safe
2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways.
Molecular pharmacology 2005;68(1):119-28.
2004: Sudhakar Chintharlapalli; Roger Smith; Ismael Samudio; Wei Zhang; Stephen Safe
1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells.
Cancer research 2004;64(17):5994-6001.